✦ LIBER ✦

The Management of Relapsed AML or MDS Following a T-Cell Depleted Allogeneic Stem Cell Transplant

✍ Scribed by Morawa, Ewelina; Zabor, Emily; Maloy, Molly; Devlin, Sean; Giralt, Sergio A.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P-219 T cell depleted (TCD) allogeneic h

✍ Tamari, R.; Chung, S.; Devlin, S.; Jakubowski, A.; Papadopoulos, E.; Perales, M. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 68 KB

The current status of T-cell depleted al

✍ Bunjes, D. 📂 Article 📅 2001 🏛 Informa plc 🌐 English ⚖ 156 KB

Favorable Outcomes in Elderly and High-R

✍ E. Nicholson; S. Mackinnon; K.J. Thomson; J. Sudak; A.K. Fielding; P. Kottaridis 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 68 KB

Treatment of AML and MDS relapsing after

✍ Oran, B; Giralt, S; Couriel, D; Hosing, C; Shpall, E J; de Meis, E; Khouri, I F; 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 138 KB

P-221 Characteristic of relapse after T

✍ Tamari, R.; Chung, S.; Devlin, S.; Jakubowski, A.; Papadopoulos, E.; Boulad, F.; 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 163 KB

Azacitidine and donor lymphocyte infusio

✍ Schroeder, T; Czibere, A; Platzbecker, U; Bug, G; Uharek, L; Luft, T; Giagounidi 📂 Article 📅 2013 🏛 Nature Publishing Group 🌐 English ⚖ 435 KB